210 related articles for article (PubMed ID: 26962537)
1. JNK1 Deficient Insulin-Producing Cells Are Protected against Interleukin-1β-Induced Apoptosis Associated with Abrogated Myc Expression.
Prause M; Mayer CM; Brorsson C; Frederiksen KS; Billestrup N; Størling J; Mandrup-Poulsen T
J Diabetes Res; 2016; 2016():1312705. PubMed ID: 26962537
[TBL] [Abstract][Full Text] [Related]
2. JNK1 protects against glucolipotoxicity-mediated beta-cell apoptosis.
Prause M; Christensen DP; Billestrup N; Mandrup-Poulsen T
PLoS One; 2014; 9(1):e87067. PubMed ID: 24475223
[TBL] [Abstract][Full Text] [Related]
3. JNK3 maintains expression of the insulin receptor substrate 2 (IRS2) in insulin-secreting cells: functional consequences for insulin signaling.
Abdelli S; Bonny C
PLoS One; 2012; 7(5):e35997. PubMed ID: 22563476
[TBL] [Abstract][Full Text] [Related]
4. JNK1/2 regulates ER-mitochondrial Ca2+ cross-talk during IL-1β-mediated cell death in RINm5F and human primary β-cells.
Verma G; Bhatia H; Datta M
Mol Biol Cell; 2013 Jun; 24(12):2058-71. PubMed ID: 23615449
[TBL] [Abstract][Full Text] [Related]
5. JNK3 is abundant in insulin-secreting cells and protects against cytokine-induced apoptosis.
Abdelli S; Puyal J; Bielmann C; Buchillier V; Abderrahmani A; Clarke PG; Beckmann JS; Bonny C
Diabetologia; 2009 Sep; 52(9):1871-80. PubMed ID: 19609503
[TBL] [Abstract][Full Text] [Related]
6. Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells.
Cui J; Wang Q; Wang J; Lv M; Zhu N; Li Y; Feng J; Shen B; Zhang J
Mol Cancer Ther; 2009 Dec; 8(12):3214-22. PubMed ID: 19996270
[TBL] [Abstract][Full Text] [Related]
7. JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells.
Yan F; Wang XM; Liu ZC; Pan C; Yuan SB; Ma QM
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):287-95. PubMed ID: 20525557
[TBL] [Abstract][Full Text] [Related]
8. Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding.
Kook S; Zhan X; Kaoud TS; Dalby KN; Gurevich VV; Gurevich EV
J Biol Chem; 2013 Dec; 288(52):37332-42. PubMed ID: 24257757
[TBL] [Abstract][Full Text] [Related]
9. Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines.
Mahalingam D; Keane M; Pirianov G; Mehmet H; Samali A; Szegezdi E
Br J Cancer; 2009 May; 100(9):1415-24. PubMed ID: 19352384
[TBL] [Abstract][Full Text] [Related]
10. Isoform-specific functions of c-Jun N-terminal kinase 1 and 2 in lung ischemia-reperfusion injury through the c-Jun/activator protein-1 pathway.
Tan J; Gao W; Yang W; Zeng X; Wang L; Cui X
J Thorac Cardiovasc Surg; 2021 Aug; 162(2):e143-e156. PubMed ID: 32414595
[TBL] [Abstract][Full Text] [Related]
11. Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha.
Kosters A; White DD; Sun H; Thevananther S; Karpen SJ
J Hepatol; 2009 Nov; 51(5):898-908. PubMed ID: 19767119
[TBL] [Abstract][Full Text] [Related]
12. Distinct role of c-Jun N-terminal kinase isoforms in human neutrophil apoptosis regulated by tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor.
Kato T; Noma H; Kitagawa M; Takahashi T; Oshitani N; Kitagawa S
J Interferon Cytokine Res; 2008 Apr; 28(4):235-43. PubMed ID: 18439101
[TBL] [Abstract][Full Text] [Related]
13. The JNK1/JNK3 interactome--contributions by the JNK3 unique N-terminus and JNK common docking site residues.
Chen WK; Yeap YY; Bogoyevitch MA
Biochem Biophys Res Commun; 2014 Oct; 453(3):576-81. PubMed ID: 25301550
[TBL] [Abstract][Full Text] [Related]
14. c-Jun N-terminal kinase 1 phosphorylates Myt1 to prevent UVA-induced skin cancer.
Choi HS; Bode AM; Shim JH; Lee SY; Dong Z
Mol Cell Biol; 2009 Apr; 29(8):2168-80. PubMed ID: 19204086
[TBL] [Abstract][Full Text] [Related]
15. TRAF2 mediates JNK and STAT3 activation in response to IL-1β and IFNγ and facilitates apoptotic death of insulin-producing β-cells.
Prause M; Berchtold LA; Urizar AI; Hyldgaard Trauelsen M; Billestrup N; Mandrup-Poulsen T; Størling J
Mol Cell Endocrinol; 2016 Jan; 420():24-36. PubMed ID: 26610752
[TBL] [Abstract][Full Text] [Related]
16. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
Liu J; Minemoto Y; Lin A
Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
[TBL] [Abstract][Full Text] [Related]
17. c-JUN N-terminal kinase-1 (JNK1) but not JNK2 or JNK3 is involved in UV signal transduction in human epidermis.
Katagiri C; Negishi K; Hibino T
J Dermatol Sci; 2006 Sep; 43(3):171-9. PubMed ID: 16824735
[TBL] [Abstract][Full Text] [Related]
18. IL-1 beta induces urokinase-plasminogen activator expression and cell migration through PKC alpha, JNK1/2, and NF-kappaB in A549 cells.
Cheng CY; Hsieh HL; Sun CC; Lin CC; Luo SF; Yang CM
J Cell Physiol; 2009 Apr; 219(1):183-93. PubMed ID: 19097143
[TBL] [Abstract][Full Text] [Related]
19. JNK1 and JNK3 play a significant role in both neuronal apoptosis and necrosis. Evaluation based on in vitro approach using tert-butylhydroperoxide induced oxidative stress in neuro-2A cells and perturbation through 3-aminobenzamide.
Muthaiah VPK; Michael FM; Palaniappan T; Rajan SS; Chandrasekar K; Venkatachalam S
Toxicol In Vitro; 2017 Jun; 41():168-178. PubMed ID: 28257805
[TBL] [Abstract][Full Text] [Related]
20. Calcium has a permissive role in interleukin-1beta-induced c-jun N-terminal kinase activation in insulin-secreting cells.
Størling J; Zaitsev SV; Kapelioukh IL; Karlsen AE; Billestrup N; Berggren PO; Mandrup-Poulsen T
Endocrinology; 2005 Jul; 146(7):3026-36. PubMed ID: 15831571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
